The Gregorio Marañón Hospital in Madrid has unveiled a groundbreaking medical innovation: the world’s first non-invasive real-time heart mapping system. This revolutionary technology, named Corify, utilizes a specialized vest equipped with electrodes that, when attached to a patient’s torso, provides a detailed three-dimensional view of the heart’s electrical activity within just ten minutes. Unlike traditional diagnostic methods, Corify eliminates the need for catheterization, CT scans, or MRIs, enhancing both patient safety and diagnostic efficiency.

Musumeci Online – The Podcast. It is perfect for driving, commuting, or waiting in line!

A Major Leap in Cardiology

Developed through two decades of research by the hospital’s Cardiology Department in collaboration with the Polytechnic University of Valencia, Corify marks a transformative advancement in cardiovascular diagnostics. It enables physicians to detect and analyze arrhythmias, including atrial fibrillation and ventricular tachycardia, conditions that affect millions worldwide and significantly increase the risk of stroke and heart failure.

Corify, however, allows specialists to examine cardiac activity externally before considering invasive interventions.

“Corify represents a new milestone in healthcare innovation,” stated Fátima Matute, Madrid’s Minister of Health, during a demonstration of the device at the Gregorio Marañón Maternal-Infant Hospital. She emphasized how this breakthrough reflects the Madrid healthcare system’s commitment to advancing medical technology.

Advantages Over Traditional Methods

Current heart-mapping techniques often require invasive procedures or are reliant on radiological imaging, which can be time-consuming, costly, and riskier for patients. Corify, however, allows specialists to examine cardiac activity externally before considering invasive interventions. It assists in identifying the exact heart regions responsible for arrhythmias, optimizing treatment decisions, and determining the best candidates for catheter-based ablation therapies. Furthermore, it prevents unnecessary procedures for patients unlikely to benefit from such interventions, ultimately reducing healthcare costs and improving clinical outcomes.

International Recognition and Market Expansion

Corify has already been tested on nearly 2,000 patients in various healthcare centers and has received CE certification, allowing for its commercial distribution across the European Union. Its impact on cardiovascular medicine has been widely acknowledged, earning the European Institute of Innovation and Technology’s ‘Innovation of the Year’ award in 2020.

The introduction of Corify not only strengthens Gregorio Marañón Hospital’s position as a global leader in medical research but also sets a new benchmark for non-invasive cardiac diagnostics. By making real-time heart mapping more accessible and safer, this innovation has the potential to transform how heart diseases are detected and treated worldwide.